10 April 2025 Decision overturns earlier decision allowing generic drug maker to launch version | Dispute centres on ...

Prompter patent issue will provide earlier protection for inventions and could avoid need for Quick Path Information ...

Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of ...

Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to ...

Firm’s chair says Fenwick has been active in market for a long time and “waiting to find the right opportunity to deepen our bench and presence”.

AstraZeneca fends off diabetes generic, for now ...

EPO: Biotech innovation strong, while pharma trails behind ...

New partner brings 16 years of experience in biotechnology and pharmaceutical patent prosecution to Chicago | Regularly advises on animal biotechnology, antibodies and biologics, cell biology, ...

The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder ...

Pharma giant dodges threat as US judge dismisses monopoly claims over its blockbuster cancer drug | FDA approves new ...

Ahead of the upcoming LSPN North America-Spring 2025 conference, chair Eldora Ellison shares insights on emerging innovations ...

Failure to make findings of fact adds twist to battle over Eliquis in Ireland ...